The following drugs were used for the pharmacological treatment of COVID-19 in the acute phase of the disease: vasopressors (5.5%), antiaggregant (19.3%), corticosteroids (60.6%), antiviral (33.9%), immunosuppressors (4.4%), antibiotics (92.6%), antifungals (6.5%), antiparasitic (7.1%), non-steroidal anti-inflammatories (23.2%), angiotensin-converting enzyme inhibitors (19.8%), angiotensin-II receptor antagonists (22.2%). Here, ACE is linked to COVID-19.